Logo image of IVDA

IVEDA SOLUTIONS INC (IVDA) Stock Fundamental Analysis

USA - NASDAQ:IVDA - US46583A3032 - Common Stock

1.9 USD
-0.13 (-6.4%)
Last: 10/3/2025, 8:00:02 PM
1.86 USD
-0.04 (-2.11%)
After Hours: 10/3/2025, 8:00:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IVDA. IVDA was compared to 281 industry peers in the Software industry. IVDA may be in some trouble as it scores bad on both profitability and health. IVDA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IVDA has reported negative net income.
IVDA had a negative operating cash flow in the past year.
In the past 5 years IVDA always reported negative net income.
IVDA had a negative operating cash flow in each of the past 5 years.
IVDA Yearly Net Income VS EBIT VS OCF VS FCFIVDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M -5M

1.2 Ratios

The Return On Assets of IVDA (-85.11%) is worse than 89.32% of its industry peers.
The Return On Equity of IVDA (-252.35%) is worse than 82.21% of its industry peers.
Industry RankSector Rank
ROA -85.11%
ROE -252.35%
ROIC N/A
ROA(3y)-58.84%
ROA(5y)-80.97%
ROE(3y)-97.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVDA Yearly ROA, ROE, ROICIVDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2019 2020 2021 2022 2023 2024 0 200 400

1.3 Margins

IVDA has a Gross Margin of 18.92%. This is amonst the worse of the industry: IVDA underperforms 81.85% of its industry peers.
IVDA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for IVDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.62%
GM growth 5Y-5.06%
IVDA Yearly Profit, Operating, Gross MarginsIVDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

IVDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
IVDA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IVDA has more shares outstanding
IVDA has a worse debt/assets ratio than last year.
IVDA Yearly Shares OutstandingIVDA Yearly Shares OutstandingYearly Shares Outstanding 2015 2019 2020 2021 2022 2023 2024 5M 10M 15M
IVDA Yearly Total Debt VS Total AssetsIVDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

IVDA has an Altman-Z score of -16.99. This is a bad value and indicates that IVDA is not financially healthy and even has some risk of bankruptcy.
IVDA has a Altman-Z score of -16.99. This is amonst the worse of the industry: IVDA underperforms 92.53% of its industry peers.
A Debt/Equity ratio of 0.60 indicates that IVDA is somewhat dependend on debt financing.
IVDA's Debt to Equity ratio of 0.60 is on the low side compared to the rest of the industry. IVDA is outperformed by 67.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z -16.99
ROIC/WACCN/A
WACC10.96%
IVDA Yearly LT Debt VS Equity VS FCFIVDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

IVDA has a Current Ratio of 1.70. This is a normal value and indicates that IVDA is financially healthy and should not expect problems in meeting its short term obligations.
IVDA has a Current ratio (1.70) which is comparable to the rest of the industry.
A Quick Ratio of 1.59 indicates that IVDA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.59, IVDA is in line with its industry, outperforming 51.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.59
IVDA Yearly Current Assets VS Current LiabilitesIVDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for IVDA have decreased by -3.14% in the last year.
The Revenue has grown by 89.10% in the past year. This is a very strong growth!
The Revenue has been growing by 10.59% on average over the past years. This is quite good.
EPS 1Y (TTM)-3.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.28%
Revenue 1Y (TTM)89.1%
Revenue growth 3Y46.37%
Revenue growth 5Y10.59%
Sales Q2Q%-0.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y264.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year229.89%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVDA Yearly Revenue VS EstimatesIVDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
IVDA Yearly EPS VS EstimatesIVDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -0.5 -1 -1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IVDA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 8.10, the valuation of IVDA can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IVDA indicates a rather cheap valuation: IVDA is cheaper than 94.66% of the companies listed in the same industry.
IVDA is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 8.1
IVDA Price Earnings VS Forward Price EarningsIVDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVDA Per share dataIVDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IVDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IVEDA SOLUTIONS INC

NASDAQ:IVDA (10/3/2025, 8:00:02 PM)

After market: 1.86 -0.04 (-2.11%)

1.9

-0.13 (-6.4%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners3.03%
Inst Owner Change0%
Ins Owners4.57%
Ins Owner Change0%
Market Cap5.53M
Analysts82.86
Price TargetN/A
Short Float %2.18%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-71.8%
Min Revenue beat(2)-73.72%
Max Revenue beat(2)-69.88%
Revenue beat(4)0
Avg Revenue beat(4)-58.72%
Min Revenue beat(4)-85.34%
Max Revenue beat(4)-5.95%
Revenue beat(8)0
Avg Revenue beat(8)-62.72%
Revenue beat(12)2
Avg Revenue beat(12)-41.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.1
P/S 0.77
P/FCF N/A
P/OCF N/A
P/B 3.73
P/tB 3.73
EV/EBITDA N/A
EPS(TTM)-1.43
EYN/A
EPS(NY)0.23
Fwd EY12.35%
FCF(TTM)-1.23
FCFYN/A
OCF(TTM)-1.33
OCFYN/A
SpS2.45
BVpS0.51
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -85.11%
ROE -252.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.92%
FCFM N/A
ROA(3y)-58.84%
ROA(5y)-80.97%
ROE(3y)-97.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.62%
GM growth 5Y-5.06%
F-Score1
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1020.14%
Cap/Sales 4.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.59
Altman-Z -16.99
F-Score1
WACC10.96%
ROIC/WACCN/A
Cap/Depr(3y)163.5%
Cap/Depr(5y)131.43%
Cap/Sales(3y)0.53%
Cap/Sales(5y)0.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.28%
EPS Next Y264.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)89.1%
Revenue growth 3Y46.37%
Revenue growth 5Y10.59%
Sales Q2Q%-0.4%
Revenue Next Year229.89%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-26.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.77%
OCF growth 3YN/A
OCF growth 5YN/A